SUSTAINED-release products have been designed to contain in one dosage form the equivalent of several single doses of a drug, which is released to the body over an extended period. This slow release ...

Treatment of chronic refractory anemias with regular blood transfusions results in iron accumulation, with potential damage to the liver, endocrine system, and heart. Each unit of blood adds 200 to ...

MR, a well-appearing 21-year-old White woman, presents to her student health clinic with a complaint of general fatigue despite being treated with iron supplementation for iron deficiency. Three years ...

"We await several ongoing clinical trials, including HEART-FID, which will be the largest trial of intravenous iron to date in patients who have heart failure with reduced ejection fraction. This ...

Iron deficiency is prevalent in up to 30% to 50% of patients with stable, chronic HF. More than 30% of these patients do not have anemia or abnormalities in hematologic indices. The prevalence is ...